Table I.

HLA-A2 adjuvant protocol

ScheduleArm1 (qw)Arm2 (q3w)Arm3 (qdx4 q3w)
Number of patients (%)
31 (100)31 (100)33 (100)
Sex
 Male17 (55)16 (52)24 (73)
 Female14 (45)15 (48)9 (27)
Age
 21–301 (3)2 (6)0 (0)
 31–406 (19)3 (10)4 (12)
 41–5011 (35)8 (26)10 (30)
 51–609 (29)12 (39)8 (24)
 61–704 (13)5 (16)10 (30)
 Over 700 (0)1 (3)1 (3)
Eligibility criteria
 Resected primary6 (19)14 (45)5 (15)
 Positive nodes19 (61)13 (42)23 (70)
 Resected mets6 (19)4 (13)5 (15)
Number of positive lymph nodes
 012 (39)18 (5)10 (30)
 1–216 (52)9 (29)10 (30)
 3–42 (6)4 (13)5 (15)
 5–60 (0)0 (0)4 (12)
 7–80 (0)0 (0)3 (9)
 9–100 (0)0 (0)1 (3)
 >101 (5)0 (0)0 (0)